Post-Polio Syndrome Surveillance

Clinical Surveillance Framework

The Centers for Disease Control and Prevention recommends that patients with a history of paralytic poliomyelitis should be monitored clinically for the development of post-polio syndrome starting 15-40 years after their acute illness, with surveillance focused on identifying new muscle weakness, fatigue, muscle pain, and bulbar or respiratory symptoms that cannot be explained by other medical conditions 1, 2
Approximately 25-40% of persons who contracted paralytic polio during childhood will develop post-polio syndrome, according to the Centers for Disease Control and Prevention 1, 2
Higher risk patients include those with greater time since acute infection, more severe permanent residual impairment after initial recovery, and female gender, as reported by the Centers for Disease Control and Prevention 4

Neutralizing antibody testing against poliovirus serotypes is for immunity assessment, not post-polio syndrome diagnosis, as stated by the Praxis Medical Insights guideline society 5